Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice

被引:112
作者
Yokoi, H. [1 ]
Mukoyama, M. [1 ]
Mori, K. [1 ]
Kasahara, M. [1 ,2 ]
Suganami, T. [1 ]
Sawai, K. [1 ]
Yoshioka, T. [1 ]
Saito, Y. [1 ]
Ogawa, Y. [1 ]
Kuwabara, T. [1 ]
Sugawara, A. [1 ]
Nakao, K. [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Sakyo Ku, Kyoto 6068507, Japan
[2] Kobe City Gen Hosp, Div Nephrol, Kobe, Hyogo, Japan
关键词
diabetic nephropathy; transgenic mice; transforming growth factor-beta; extracellular matrix; podocyte;
D O I
10.1038/sj.ki.5002722
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Connective tissue growth factor (CTGF) is a potent inducer of extracellular matrix accumulation. In diabetic nephropathy, CTGF expression is markedly upregulated both in podocytes and mesangial cells, and this may play an important role in its pathogenesis. We established podocyte-specific CTGF-transgenic mice, which were indistinguishable at baseline from their wild-type littermates. Twelve weeks after streptozotocin-induced diabetes, these transgenic mice showed a more severe proteinuria, mesangial expansion, and a decrease in matrix metalloproteinase-2 activity compared to diabetic wild-type mice. Furthermore, diabetic transgenic mice exhibited less podocin expression and a decreased number of diffusely vacuolated podocytes compared to diabetic wild-type mice. Importantly, induction of diabetes in CTGF-transgenic mice resulted in a further elevation of endogenous CTGF mRNA expression and protein in the glomerular mesangium. Our findings suggest that overexpression of CTGF in podocytes is sufficient to exacerbate proteinuria and mesangial expansion through a functional impairment and loss of podocytes.
引用
收藏
页码:446 / 455
页数:10
相关论文
共 49 条
[1]   Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy [J].
Andersen, S ;
van Nieuwenhoven, FA ;
Tarnow, L ;
Rossing, P ;
Rossing, K ;
Wieten, L ;
Goldschmeding, R ;
Parving, HH .
KIDNEY INTERNATIONAL, 2005, 67 (06) :2325-2329
[2]   Connective tissue growth factor is crucial to inducing a profibrotic environment in "fibrosis-resistant" Balb/c mouse lungs [J].
Bonniaud, P ;
Martin, G ;
Margetts, PJ ;
Ask, K ;
Robertson, J ;
Gauldie, J ;
Kolb, M .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 31 (05) :510-516
[3]   NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome [J].
Boute, N ;
Gribouval, O ;
Roselli, S ;
Benessy, F ;
Lee, H ;
Fuchshuber, A ;
Dahan, K ;
Gubler, MC ;
Niaudet, P ;
Antignac, C .
NATURE GENETICS, 2000, 24 (04) :349-354
[4]   CONNECTIVE-TISSUE GROWTH-FACTOR - A CYSTEINE-RICH MITOGEN SECRETED BY HUMAN VASCULAR ENDOTHELIAL-CELLS IS RELATED TO THE SRC-INDUCED IMMEDIATE EARLY GENE-PRODUCT CEF-10 [J].
BRADHAM, DM ;
IGARASHI, A ;
POTTER, RL ;
GROTENDORST, GR .
JOURNAL OF CELL BIOLOGY, 1991, 114 (06) :1285-1294
[5]   Proposal for a unified CCN nomenclature [J].
Brigstock, DR ;
Goldschmeding, R ;
Katsube, K ;
Lam, SCT ;
Lau, LF ;
Lyons, K ;
Naus, C ;
Perbal, B ;
Riser, B ;
Takigawa, M ;
Yeger, H .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 2003, 56 (02) :127-128
[6]   Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis:: downregulation by cAMP [J].
Duncan, MR ;
Frazier, KS ;
Abramson, S ;
Williams, S ;
Klapper, H ;
Huang, XF ;
Grotendorst, GR .
FASEB JOURNAL, 1999, 13 (13) :1774-1786
[7]   Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases [J].
Eremina, V ;
Sood, M ;
Haigh, J ;
Nagy, A ;
Lajoie, G ;
Ferrara, N ;
Gerber, HP ;
Kikkawa, Y ;
Miner, JH ;
Quaggin, SE .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :707-716
[8]   Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor [J].
Frazier, K ;
Williams, S ;
Kothapalli, D ;
Klapper, H ;
Grotendorst, GR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (03) :404-411
[9]   Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes [J].
Guha, Mausumee ;
Xu, Zhong-Gao ;
Tung, David ;
Lanting, Linda ;
Natarajan, Rama .
FASEB JOURNAL, 2007, 21 (12) :3355-3368
[10]   Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis [J].
Gupta, S ;
Clarkson, MR ;
Duggan, J ;
Brady, HR .
KIDNEY INTERNATIONAL, 2000, 58 (04) :1389-1399